(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | 13.90%5.1B | ---- | 15.12%8.63B | ---- | -6.43%4.48B | ---- | 1.10%7.5B | ---- | 17.58%4.78B |
Profit adjustment | ||||||||||
Interest expense - adjustment | ---- | 946.88%5.69M | ---- | 35.29%14.94M | ---- | -112.44%-672K | ---- | -3.79%11.04M | ---- | -4.93%5.4M |
Dividend (income)- adjustment | ---- | 93.20%-6.67M | ---- | -48.95%-167.06M | ---- | -330.93%-98.13M | ---- | -294.55%-112.16M | ---- | -56.69%-22.77M |
Attributable subsidiary (profit) loss | ---- | 39.11%-21.74M | ---- | -140.70%-87.64M | ---- | -124.82%-35.71M | ---- | 36.44%215.35M | ---- | 74.11%143.88M |
Impairment and provisions: | ---- | 456.24%873.38M | ---- | -25.08%891.61M | ---- | -92.88%157.01M | ---- | -37.52%1.19B | ---- | 38.35%2.21B |
-Impairment of property, plant and equipment (reversal) | ---- | --104.37M | ---- | 61.08%190.64M | ---- | ---- | ---- | -83.66%118.35M | ---- | -88.41%78.45M |
-Impairmen of inventory (reversal) | ---- | 208.48%598.59M | ---- | -16.76%633.36M | ---- | -90.27%194.05M | ---- | 144.53%760.86M | ---- | 394.63%1.99B |
-Impairment of trade receivables (reversal) | ---- | 209.45%109.59M | ---- | -111.21%-21.77M | ---- | -665.95%-100.12M | ---- | 31.36%194.18M | ---- | -0.46%17.69M |
-Impairment of goodwill | ---- | --17.19M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Other impairments and provisions | ---- | -30.84%43.63M | ---- | -23.42%89.39M | ---- | -45.26%63.09M | ---- | -83.82%116.72M | ---- | -76.81%115.26M |
Revaluation surplus: | ---- | 20.32%-347.02M | ---- | -151.81%-419.68M | ---- | 47.13%-435.54M | ---- | 284.58%810.01M | ---- | -395.45%-823.79M |
-Derivative financial instruments fair value (increase) | ---- | 3.40%-297.04M | ---- | -158.90%-354.4M | ---- | 68.76%-307.49M | ---- | 376.41%601.72M | ---- | -154.66%-984.24M |
-Other fair value changes | ---- | 60.97%-49.98M | ---- | -131.34%-65.28M | ---- | -179.81%-128.04M | ---- | -51.37%208.29M | ---- | -27.14%160.44M |
Asset sale loss (gain): | ---- | 117.96%10.36M | ---- | 45.52%-31.61M | ---- | 69.26%-57.69M | ---- | -163.65%-58.02M | ---- | -1,280.43%-187.68M |
-Loss (gain) from sale of subsidiary company | ---- | 107.33%2.55M | ---- | 54.72%-82.44M | ---- | 81.28%-34.75M | ---- | -587.67%-182.09M | ---- | ---185.68M |
-Loss (gain) on sale of property, machinery and equipment | ---- | 134.07%7.82M | ---- | -51.58%50.83M | ---- | -1,046.28%-22.94M | ---- | -19.07%104.97M | ---- | -106.79%-2M |
-Loss (gain) from selling other assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 258.25%19.1M | ---- | ---- |
Depreciation and amortization: | ---- | 6.50%1.45B | ---- | 4.52%2.85B | ---- | 0.65%1.36B | ---- | -1.31%2.72B | ---- | -8.30%1.35B |
-Amortization of intangible assets | ---- | -4.41%132.61M | ---- | 6.36%258.38M | ---- | 16.05%138.73M | ---- | -11.38%242.94M | ---- | -23.90%119.55M |
Financial expense | ---- | 4.16%1.19B | ---- | 18.13%2.32B | ---- | 1.72%1.15B | ---- | -2.56%1.97B | ---- | 8.74%1.13B |
Exchange Loss (gain) | ---- | 230.67%202.17M | ---- | 27.61%-172.14M | ---- | 34.14%-154.72M | ---- | -3,389.44%-237.81M | ---- | -312.27%-234.91M |
Special items | ---- | 5.51%-81.71M | ---- | -4.84%-377.45M | ---- | 4.02%-86.48M | ---- | 6.59%-360.01M | ---- | -218.93%-90.11M |
Operating profit before the change of operating capital | ---- | 33.56%8.38B | ---- | -1.42%13.46B | ---- | -24.06%6.27B | ---- | -3.55%13.65B | ---- | 4.11%8.26B |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | -960.79%-11.28B | ---- | -120.69%-3.22B | ---- | 23.48%-1.06B | ---- | 70.95%-1.46B | ---- | 80.88%-1.39B |
Accounts receivable (increase)decrease | ---- | -2,106.56%-1.91B | ---- | -42.21%433.62M | ---- | 91.46%-86.54M | ---- | 163.60%750.39M | ---- | -14.09%-1.01B |
Accounts payable increase (decrease) | ---- | 1,191.92%5.76B | ---- | 269.24%1.71B | ---- | -89.33%445.6M | ---- | -87.79%464.3M | ---- | 496.59%4.18B |
prepayments (increase)decrease | ---- | -87.85%-6.1B | ---- | 5.17%-360.5M | ---- | 24.16%-3.25B | ---- | 68.10%-380.17M | ---- | -179.22%-4.28B |
Derivative financial instruments (increase) decrease | ---- | 10.06%-475.49M | ---- | -40.79%3.23M | ---- | 41.08%-528.68M | ---- | -53.37%5.45M | ---- | -129.70%-897.28M |
Special items for working capital changes | ---- | -65.03%2.08B | ---- | 152.81%436.67M | ---- | 85.61%5.95B | ---- | -169.54%-826.94M | ---- | 933.73%3.21B |
Cash from business operations | ---- | -145.84%-3.55B | ---- | 2.15%12.47B | ---- | -3.91%7.74B | ---- | 18.82%12.21B | ---- | 254.33%8.06B |
Other taxs | ---- | 2.27%-1.25B | ---- | 1.77%-1.54B | ---- | -77.60%-1.28B | ---- | -26.04%-1.56B | ---- | -42.01%-720.19M |
Adjustment items of business operations | -93.98%495.43M | ---- | -51.54%-6.07B | ---- | -22.34%8.23B | ---- | -106.12%-4B | ---- | 31.38%10.6B | ---- |
Net cash from operations | -93.98%495.43M | -174.24%-4.8B | -51.54%-6.07B | 2.72%10.93B | -22.34%8.23B | -11.91%6.46B | -106.12%-4B | 17.82%10.64B | 31.38%10.6B | 315.25%7.34B |
Cash flow from investment activities | ||||||||||
Dividend received - investment | -45.83%247.66M | -83.31%7.08M | 59.49%192.91M | 125.79%137.29M | -62.24%457.19M | 99.77%42.41M | 9.77%120.95M | -5.94%60.81M | 224.36%1.21B | -63.54%21.23M |
Sale of fixed assets | 4.85%30.07M | -83.56%4.65M | -98.17%177.35K | -74.87%45.49M | -77.99%28.68M | -56.82%28.29M | -41.03%9.67M | 102.45%180.99M | -31.86%130.3M | 54.85%65.52M |
Purchase of fixed assets | -6.39%-3.69B | 5.81%-2.66B | 43.89%-688.89M | -26.44%-6.52B | -38.45%-3.47B | -79.46%-2.83B | -121.62%-1.23B | -92.67%-5.16B | -138.39%-2.5B | -106.59%-1.58B |
Selling intangible assets | ---- | ---- | ---- | 219.38%725K | ---- | ---- | ---- | -98.78%227K | ---- | 0.63%20.54M |
Purchase of intangible assets | ---- | 74.96%-37.95M | ---- | -97.84%-288.76M | ---- | -7.38%-151.55M | ---- | 16.17%-145.96M | ---- | -55.76%-141.13M |
Sale of subsidiaries | ---- | ---- | ---- | -98.01%4.86M | ---- | -100.35%-854K | ---- | --243.68M | --61.41M | --243.32M |
Acquisition of subsidiaries | ---- | ---- | ---- | ---133.7M | ---137.48M | ---137.49M | ---- | ---- | ---- | ---- |
Recovery of cash from investments | 50.79%13.2B | 113.99%6.96B | 96.97%5.78B | -21.79%20.92B | -14.88%8.75B | -58.11%3.25B | 42.66%2.93B | 33.58%26.75B | -19.52%10.28B | -12.36%7.76B |
Cash on investment | -6.60%-23.52B | -6.75%-17.42B | -84.22%-8.05B | 24.50%-22.4B | 1.16%-22.06B | 6.70%-16.31B | 9.89%-4.37B | -44.87%-29.66B | -36.55%-22.32B | -59.31%-17.49B |
Other items in the investment business | ---- | ---- | ---- | -108.34%-747K | ---- | ---- | ---- | 144.54%8.95M | 4,382.18%728.6M | ---- |
Net cash from investment operations | 16.43%-13.73B | 18.39%-13.15B | -9.16%-2.76B | -6.60%-8.23B | -32.37%-16.43B | -45.25%-16.11B | 21.35%-2.53B | -139.06%-7.72B | -183.29%-12.41B | -262.58%-11.09B |
Net cash before financing | -61.42%-13.23B | -86.08%-17.95B | -35.13%-8.83B | -7.51%2.7B | -352.28%-8.2B | -157.04%-9.65B | -26.64%-6.54B | -49.64%2.92B | -149.17%-1.81B | -190.52%-3.75B |
Cash flow from financing activities | ||||||||||
New borrowing | 25.50%94.49B | 26.41%97.41B | -19.04%15.88B | 10.45%108.35B | 11.08%75.29B | 14.60%77.06B | -16.75%19.62B | 11.36%98.1B | -9.81%67.78B | 18.35%67.24B |
Refund | -74.56%-63.84B | -86.32%-59.75B | 10.24%-11.6B | -2.27%-92.89B | 13.90%-36.57B | 24.05%-32.07B | 27.20%-12.93B | -19.90%-90.83B | 23.13%-42.47B | -4.70%-42.23B |
Issuance of bonds | ---- | -60.43%585.05M | ---- | -33.42%2B | ---- | 47.84%1.48B | ---- | 100.00%3B | ---- | --1B |
Interest paid - financing | ---- | -50.72%-1.31B | ---- | -149.42%-1.84B | ---- | -16.60%-870.87M | ---- | 36.46%-736.16M | ---- | -9.35%-746.88M |
Dividends paid - financing | -10.12%-3.3B | ---92.56M | -3.92%-333.85M | -9.87%-1.96B | 38.82%-2.99B | ---- | -1.59%-321.27M | -293.03%-1.78B | -286.65%-4.89B | 38.99%-29.16M |
Absorb investment income | -27.93%305.06M | -31.02%291.97M | -94.90%10.2M | 81.26%468.11M | 141.87%423.27M | 141.87%423.27M | --200.08M | -68.49%258.25M | --175M | --175M |
Issuance expenses and redemption of securities expenses | ---- | ---258.75M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Other items of the financing business | 14.68%-16.2B | 37.36%-15.95B | -249.83%-895.73M | 31.60%-12.01B | -25.88%-18.98B | -40.50%-25.46B | 61.33%597.85M | -50.29%-17.56B | -31.10%-15.08B | -65.43%-18.12B |
Net cash from financing operations | -33.22%11.47B | 1.78%20.83B | -57.33%3.06B | 119.82%1.93B | 211.78%17.17B | 184.57%20.47B | 22.29%7.17B | -945.26%-9.75B | -22.75%5.51B | 52.91%7.19B |
Effect of rate | -37.07%151.23M | -90.63%32.65M | 117.10%46.36M | -54.09%121.22M | 703.99%240.3M | -5.01%348.32M | -1,796.40%-271.05M | 333.21%264.05M | -441.32%-39.79M | 1,257.22%366.7M |
Net Cash | -119.69%-1.77B | -73.35%2.88B | -1,014.44%-5.77B | 167.86%4.64B | 142.85%8.97B | 214.59%10.82B | -9.74%631.37M | -198.20%-6.83B | -65.84%3.69B | 0.82%3.44B |
Begining period cash | 32.30%19.48B | 32.30%19.48B | 32.30%19.48B | -30.84%14.73B | -30.84%14.73B | -30.84%14.73B | -30.84%14.73B | 47.35%21.3B | 47.35%21.3B | 47.35%21.3B |
Cash at the end | -25.35%17.87B | -13.51%22.4B | -8.82%13.76B | 32.30%19.48B | -4.05%23.94B | 3.18%25.9B | -31.36%15.09B | -30.84%14.73B | -1.22%24.95B | 40.77%25.1B |
Cash balance analysis | ||||||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
Auditor | -- | -- | -- | Ernst & Young Huaming (Special General Partnership), Ernst & Young | -- | -- | -- | Ernst & Young Huaming (Special General Partnership), Ernst & Young | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data